[{"address1": "3891 Ranchero Drive", "address2": "Suite 150", "city": "Ann Arbor", "state": "MI", "zip": "48108", "country": "United States", "phone": "734 887 3903", "website": "https://www.esperion.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C) in the United States. The company's marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. Its products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. It has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.", "fullTimeEmployees": 304, "companyOfficers": [{"maxAge": 1, "name": "Mr. Sheldon L. Koenig M.B.A.", "age": 58, "title": "President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 1262378, "exercisedValue": 0, "unexercisedValue": 18056}, {"maxAge": 1, "name": "Mr. Benjamin  Halladay M.B.A.", "age": 38, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2024, "totalPay": 713958, "exercisedValue": 0, "unexercisedValue": 5625}, {"maxAge": 1, "name": "Mr. Benjamin O. Looker J.D.", "age": 42, "title": "General Counsel & Corporate Secretary", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 696350, "exercisedValue": 0, "unexercisedValue": 4219}, {"maxAge": 1, "name": "Tiffany  Aldrich M.B.A.", "title": "Associate Director of Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Betty Jean Swartz", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Glenn P. Brame", "age": 66, "title": "Chief Technical Operations Officer", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Pinkosky", "title": "Vice President of Drug Discovery of Early Pre-Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.65, "open": 2.6, "dayLow": 2.59, "dayHigh": 2.835, "regularMarketPreviousClose": 2.65, "regularMarketOpen": 2.6, "regularMarketDayLow": 2.59, "regularMarketDayHigh": 2.835, "payoutRatio": 0.0, "beta": 0.961, "forwardPE": 13.75, "volume": 5462994, "regularMarketVolume": 5462994, "averageVolume": 7093346, "averageVolume10days": 9363850, "averageDailyVolume10Day": 9363850, "bid": 2.74, "ask": 2.75, "bidSize": 1, "askSize": 3, "marketCap": 636962816, "fiftyTwoWeekLow": 0.69, "fiftyTwoWeekHigh": 3.94, "allTimeHigh": 120.96, "allTimeLow": 0.69, "priceToSalesTrailing12Months": 2.375619, "fiftyDayAverage": 2.4812, "twoHundredDayAverage": 1.67405, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1066579776, "profitMargins": -0.38796002, "floatShares": 200213481, "sharesOutstanding": 231622825, "sharesShort": 27694381, "sharesShortPriorMonth": 22348965, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.1374, "heldPercentInsiders": 0.00453, "heldPercentInstitutions": 0.43943, "shortRatio": 3.93, "shortPercentOfFloat": 0.138, "impliedSharesOutstanding": 231622825, "bookValue": -2.166, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -104022000, "trailingEps": -0.54, "forwardEps": 0.2, "enterpriseToRevenue": 3.978, "enterpriseToEbitda": -30.18, "52WeekChange": 0.3349514, "SandP52WeekChange": 0.13837254, "quoteType": "EQUITY", "currentPrice": 2.75, "targetHighPrice": 16.0, "targetLowPrice": 1.6, "targetMeanPrice": 6.08571, "targetMedianPrice": 4.0, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 86061000, "totalCashPerShare": 0.427, "ebitda": -35341000, "totalDebt": 598177984, "quickRatio": 0.649, "currentRatio": 1.147, "totalRevenue": 268124992, "revenuePerShare": 1.367, "returnOnAssets": -0.06335, "grossProfits": 123958000, "freeCashflow": -120302496, "operatingCashflow": -124327000, "revenueGrowth": 0.116, "grossMargins": 0.46231, "ebitdaMargins": -0.13181, "operatingMargins": 0.08612, "financialCurrency": "USD", "symbol": "ESPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.77358, "regularMarketPrice": 2.75, "corporateActions": [], "postMarketTime": 1760743827, "regularMarketTime": 1760731201, "exchange": "NGM", "messageBoardId": "finmb_28236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1372253400000, "marketState": "CLOSED", "postMarketChangePercent": 0.719998, "postMarketPrice": 2.7698, "postMarketChange": 0.0197999, "regularMarketChange": 0.0999999, "regularMarketDayRange": "2.59 - 2.835", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 7093346, "fiftyTwoWeekLowChange": 2.06, "fiftyTwoWeekLowChangePercent": 2.9855072, "fiftyTwoWeekRange": "0.69 - 3.94", "fiftyTwoWeekHighChange": -1.19, "fiftyTwoWeekHighChangePercent": -0.30203047, "fiftyTwoWeekChangePercent": 33.49514, "earningsTimestamp": 1754397000, "earningsTimestampStart": 1762259400, "earningsTimestampEnd": 1762259400, "earningsCallTimestampStart": 1754395200, "earningsCallTimestampEnd": 1754395200, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.54, "epsForward": 0.2, "epsCurrentYear": 0.01571, "priceEpsCurrentYear": 175.04774, "fiftyDayAverageChange": 0.26880002, "fiftyDayAverageChangePercent": 0.10833468, "twoHundredDayAverageChange": 1.07595, "twoHundredDayAverageChangePercent": 0.6427228, "priceToBook": -1.2696215, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "shortName": "Esperion Therapeutics, Inc.", "longName": "Esperion Therapeutics, Inc.", "displayName": "Esperion Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-18"}]